nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comprehensive analysis of the current strategy for developing live attenuated vaccines against African swine fever: A systematic review and meta-analysis
|
Ntakiyisumba, Eurade |
|
|
57 |
C |
p. |
artikel |
2 |
A novel immunogen comprising a bc loop and mutant fusion loop epitopes generates potent neutralization and protective abilities against flaviviruses without risk of disease enhancement
|
Lien, Shiu-Bii |
|
|
57 |
C |
p. |
artikel |
3 |
Assessing measles immunity among healthcare workers, a systematic review of peer-reviewed literature (2013−2023). Where do we go from here?
|
Ng, Yuen Fung |
|
|
57 |
C |
p. |
artikel |
4 |
BactiVac, the Bacterial Vaccines Network
|
MacLennan, Calman A. |
|
|
57 |
C |
p. |
artikel |
5 |
Bridging the gap: A mixed-methods analysis of Canadian and U.S. immunization programs for enhancing racial equity in childhood vaccinations
|
Gellert, Frances R. |
|
|
57 |
C |
p. |
artikel |
6 |
Can levels of HPV vaccine knowledge mitigate HPV vaccine hesitation among guardians of children aged 9–14 years? A moderated mediation model
|
Xiong, Yan |
|
|
57 |
C |
p. |
artikel |
7 |
Corrigendum to “Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine” [Vaccine (2015) 33(1) 108–16]
|
Carter, D.M. |
|
|
57 |
C |
p. |
artikel |
8 |
Editorial Board
|
|
|
|
57 |
C |
p. |
artikel |
9 |
Enhanced immunogenicity of an mRNA vaccine against dengue virus serotype 2 with modified key residue
|
Kumari, Monika |
|
|
57 |
C |
p. |
artikel |
10 |
Factors influencing influenza vaccine uptake among adults in Johannesburg, South Africa: A qualitative study
|
Mashamba, Mulalo |
|
|
57 |
C |
p. |
artikel |
11 |
Herpes simplex virus 1 fusion glycoprotein B H516P prefusion mutation had no effect on vaccine immunogenicity
|
Hu, Jingping |
|
|
57 |
C |
p. |
artikel |
12 |
Intranasal vaccination with multi-neuraminidase and M2e virus-like particle vaccine results in greater mucosal immunity and protection against influenza than intramuscular injection
|
Raha, Jannatul Ruhan |
|
|
57 |
C |
p. |
artikel |
13 |
Measles-mumps-rubella booster and post-COVID-19 immunity: A retrospective cohort study
|
Štěpánek, Ladislav |
|
|
57 |
C |
p. |
artikel |
14 |
Modulation of immune responses induced by recombinant BCG expressing LTAK63 adjuvant in an immunotherapeutic model vaccine
|
Navarrete, Josselyn Andrea Yaguana |
|
|
57 |
C |
p. |
artikel |
15 |
Mpox vaccine eligibility, uptake and coverage among gay, bisexual and other men who have sex with men in Aotearoa New Zealand
|
Saxton, Peter |
|
|
57 |
C |
p. |
artikel |
16 |
New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada
|
Rouleau, Isabelle |
|
|
57 |
C |
p. |
artikel |
17 |
Non-specific effects of routine vaccinations on child survival between 12-59 months of age in Jigawa, Nigeria: A secondary analysis of the INSPIRING Jigawa trial
|
Patrick, Elizabeth |
|
|
57 |
C |
p. |
artikel |
18 |
Reactance as a cause of COVID-19 vaccination hesitancy
|
Adame, Bradley J. |
|
|
57 |
C |
p. |
artikel |
19 |
Rebuilding Public Trust: Factors Influencing Dengue Vaccine Uptake in the Aftermath of the Dengvaxia Controversy in the Philippines: A Partial Least Structural Equation Modeling Approach
|
Gumasing, Ma Janice J. |
|
|
57 |
C |
p. |
artikel |
20 |
Serological correlates of protection and long-term efficacy of a novel recombinant protective antigen-based anthrax vaccine in a rabbit model
|
Kim, Gyu-Lee |
|
|
57 |
C |
p. |
artikel |
21 |
Serotype dynamics of Streptococcus pneumoniae in some countries in Eastern Europe and Central Asia
|
Sidorenko, Sergey V. |
|
|
57 |
C |
p. |
artikel |
22 |
Socio-economic inequalities in uptake and timing of childhood vaccination: Taking a life course approach in an administrative cohort in Scotland
|
Pearce, A. |
|
|
57 |
C |
p. |
artikel |
23 |
Trained immunity-based Adjuvated vaccines (TIbAV) approach: β-glucans as example
|
Angulo, Miriam |
|
|
57 |
C |
p. |
artikel |
24 |
What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization
|
Varma, Anshu |
|
|
57 |
C |
p. |
artikel |